TED@State Street was a TED-curated event featuring a diverse group of speakers from across the State Street organization. Jointly produced by TED and State Street, the event explored the forces driving change today and the different ways that we can harness them. Learn more about the TED Institute
Morgana Bailey has been hiding her true self for 16 years. In a brave talk, she utters four words that might not seem like a big deal to some, but to her have been paralyzing. Why speak up? Because she’s realized that her silence has personal, professional and societal consequences. In front of an audience of her co-workers, she reflects on what it means to fear the judgement of others, and how it makes us judge ourselves.
An epidemic of bad, inefficient, overcrowded meetings is plaguing the world’s businesses — and making workers miserable. David Grady has some ideas on how to stop it.
During the financial crisis, the central banks of the United States, United Kingdom and Japan created $3.7 trillion in order to buy assets and encourage investors to do the same. Michael Metcalfe offers a shocking idea: could these same central banks print money to ensure they stay on track with their goals for global aid? Without risking inflation?
Sustainability is pretty clearly one of the world's most important goals; but what groups can really make environmental progress in leaps and bounds? Chris McKnett makes the case that it's large institutional investors. He shows how strong financial data isn't enough, and reveals why investors need to look at a company's environmental, social and governance structures, too.
Humanity's fine-tuned sense of fear served us well as a young species, giving us laser focus to avoid being eaten by competing beasts. But it's less wonderful when that same visceral, body-hijacking sense of fear kicks in in front of 20 folk-music fans at a Tuesday night open-mic. Palms sweat, hands shake, vision blurs, and the brain says RUN: it's stage fright. In this charming, tuneful little talk, Joe Kowan talks about how he conquered it.
Believe it or not, about 20 years' worth of potentially life-saving drugs are sitting in labs right now, untested. Why? Because they can't get the funding to go to trials; the financial risk is too high. Roger Stein is a finance guy, and he thinks deeply about mitigating risk. He and some colleagues at MIT came up with a promising new financial model that could move hundreds of drugs into the testing pipeline.